C
Costantino Iadecola
Researcher at Cornell University
Publications - 468
Citations - 59815
Costantino Iadecola is an academic researcher from Cornell University. The author has contributed to research in topics: Stroke & Ischemia. The author has an hindex of 107, co-authored 435 publications receiving 51044 citations. Previous affiliations of Costantino Iadecola include University of Chicago & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.
Vladimir Hachinski,Karl M. Einhäupl,Detlev Ganten,Suvarna Alladi,Carol Brayne,Blossom C. M. Stephan,Melanie D. Sweeney,Berislav V. Zlokovic,Yasser Iturria-Medina,Costantino Iadecola,Nozomi Nishimura,Chris B. Schaffer,Shawn N. Whitehead,Sandra E. Black,Leif Østergaard,Leif Østergaard,Joanna M. Wardlaw,Steven M. Greenberg,Leif Friberg,Bo Norrving,Brian H. Rowe,Yves Joanette,Werner Hacke,Lewis H. Kuller,Martin Dichgans,Martin Dichgans,Matthias Endres,Zaven S. Khachaturian +27 more
TL;DR: Accumulating evidence suggests that whole populations experiencing improved education, and lower vascular risk factor profiles and vascular disease, including stroke, have better cognitive function and lower dementia rates and the World Stroke Organization has issued a proclamation calling for the joint prevention of stroke and dementia.
Journal ArticleDOI
Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation.
Lidia Garcia-Bonilla,Rose Sciortino,Ziasmin Shahanoor,Gianfranco Racchumi,Mathangi Janakiraman,Joan Montaner,Ping Zhou,Josef Anrather,Costantino Iadecola +8 more
TL;DR: This paper found that microglial CD36 is a key determinant of post-ischemic IL-1β production by regulating caspase-1 activity, whereas endothelial CD36 was required for the full expression of the endothelial activation induced by IL 1β.
Posted ContentDOI
Endogenous protection from ischemic brain injury by preconditioned monocytes
Lidia Garcia-Bonilla,David Brea,Corinne Benakis,Diane A. Lane,Michelle Murphy,Jamie Moore,Gianfranco Racchumi,Xinran Jiang,Costantino Iadecola,Josef Anrather +9 more
TL;DR: This model of neuroprotection may facilitate clinical efforts to increase the efficacy of bone marrow mononuclear cell treatments in acute neurological diseases such as cerebral ischemia and provide the rationale for cell therapies based on the delivery of autologous or allogeneic protective monocytes into patients with ischemic stroke.
Journal ArticleDOI
Vascular Cognitive Impairment: Small Vessels, Big Toll Introduction
TL;DR: The emphasis was on cerebrovascular dysregulation and small vessel white matter disease, drawing from animal models, human pathology, neuroimaging, epidemiology, and the recent clinical trial in CADASIL, as summarized below.
Journal ArticleDOI
Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events
Santosh B. Murthy,Xian Wu,Iván Díaz,Melvin Parasram,Neal S. Parikh,Costantino Iadecola,Alexander E Merkler,Guido J. Falcone,Stacy C Brown,Alessandro Biffi,Judy H. Ch’ang,Jared Knopman,Philip E. Stieg,Babak B. Navi,Kevin N. Sheth,Hooman Kamel +15 more
TL;DR: A heightened risk of arterial isChemic events driven by an increased risk of ischemic stroke, in the 4 weeks after nontraumatic SDH is found, due to interruption of antithrombotic therapy after SDH diagnosis.